Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology. ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that it had entered into a license and supply agreement with Cresilon, Inc. to market and sell the Vetigel hemostatic gel product line on an exclusive basis in the United States and on a non-exclusive basis outside the United States.Under the terms of the agreement, Zomedica will assume responsibility for supplying U.S. customers and will collaborate with Cresilon to support customers outside the U.S. This partnership enables Zomedica to further its mission of delivering innovative solutions that enhance patient care and operational efficiency for veterinary practitioners."This partnership with Zomedica is ideal for the future of Vetigel," said Joe Landolina, CEO of Cresilon. "Zomedica's established